As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.
Stephen Robinson
Advertisement
Articles by Stephen Robinson
Advertisement
Latest Updated Articles
How the Rise in Self-Injectables Is Impacting Pharmaceutical ManufacturingPublished: May 6th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
What the Closure of a Single Plant Reveals About US Drug Resilience
2
DHL Supply Chain Opens 1-Million-Square-Foot Life Sciences Distribution Center in Pennsylvania, Expanding Healthcare Logistics Footprint
3
GoodRx Offers FDA-Approved Wegovy Pill at $149 Monthly Cash Price Across US Pharmacies
4
Pharma Pulse: FDA Fast-Tracks Merck Blockbusters, GSK’s Precision Data Bet, and DHL’s Massive PA Hub
5